Disc Medicine, Inc.
IRON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $97 | $69 | $33 | $25 |
| G&A Expenses | $33 | $22 | $14 | $6 |
| SG&A Expenses | $33 | $22 | $14 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $130 | $91 | $47 | $31 |
| Operating Income | -$130 | -$91 | -$47 | -$31 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $21 | $15 | $1 | -$5 |
| Pre-Tax Income | -$109 | -$76 | -$47 | -$36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$109 | -$76 | -$47 | -$36 |
| % Margin | – | – | – | – |
| EPS | -3.96 | -3.42 | -45.05 | -44.88 |
| % Growth | -15.8% | 92.4% | -0.4% | – |
| EPS Diluted | -3.96 | -3.42 | -45.05 | -44.88 |
| Weighted Avg Shares Out | 28 | 22 | 1 | 1 |
| Weighted Avg Shares Out Dil | 28 | 22 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21 | $15 | $1 | $0 |
| Interest Expense | $1 | $0 | $0 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$108 | -$76 | -$47 | -$31 |
| % Margin | – | – | – | – |